ArticleAmerican journal of nuclear medicine and molecular imaging2021
Mapping COVID-19 with nuclear imaging: from infection to functional sequelae.
Article in American journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- PET imaging of AAV9 and AAVBR1 trafficking in normal mice.Scientific reports · 2025Article
- Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2.European journal of nuclear medicine and molecular imaging · 2024Article
- Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data.Frontiers in medicine · 2022Review
- New wine in old bottles:American journal of nuclear medicine and molecular imaging · 2021Article
- High-performance renal imaging with a radiolabeled, non-excretable chimeric fusion protein.Theranostics · 2021Article
- Implementation of level-2 biosafety for a macromolecular crystallography beamline at SSRF.American journal of nuclear medicine and molecular imaging · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or coronavirus disease 2019, COVID-19) has been raging all over the globe for more than one year. COVID-19 virus can attack multiple organs through binding to angiotensin-converting enzyme 2 (ACE2) receptors and further induce systemic inflammation and immune dysregulation. In the last issue of 2020 AJNMMI (http://www.ajnmmi.us), Lima
Indexed as
Identifiers
33688456PMC7936251W3134730644What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.